Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$671K Buy
64,633
+10,157
+19% +$107K ﹤0.01% 3594
2026
Q1
$493K Buy
54,476
+3,776
+7% +$45.6K ﹤0.01% 3621
2025
Q4
$626K Sell
50,700
-1,748
-3% -$23.3K ﹤0.01% 3576
2025
Q3
$702K Buy
+52,448
New +$717K ﹤0.01% 3538

Other funds holding CARL

Northern Trust's CARL Position: Q2 2026 in Review

Northern Trust increased its Carlsmed (CARL) stake by 19% in Q2 2026, buying an estimated $107K and bringing the position to 64,633 shares worth $671K. The position accounts for ﹤0.01% of the portfolio, ranked #3594.

Northern Trust first reported a position in CARL in Q3 2025 and has held it in 4 quarters since. The position peaked at $702K in Q3 2025. 74 funds tracked by Wall St. Rank hold CARL as of Q2 2026.

  • Northern Trust held 64,633 shares of Carlsmed worth $671K as of Q2 2026.
  • Northern Trust bought 10,157 Carlsmed shares in Q2 2026, an estimated $107K.
  • Carlsmed made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3594 holding.
  • Northern Trust first reported a position in Carlsmed in Q3 2025 and has held it in 4 quarters since.
  • Northern Trust's Carlsmed position peaked at $702K in Q3 2025.
  • 74 funds tracked by Wall St. Rank held Carlsmed as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.